Cancer risk
Cancer risk calculator: which check fits you?
There is no single calculator for your overall cancer risk. Each check on this site answers one question about one cancer: when to start screening, what your risk is, or whether a family history needs a closer look. Pick the question you have below.
Screening advice is for people without symptoms. If you have a symptom, such as a lump in a testicle, a mouth sore that lasts, blood in your urine or a mole that changes, see a doctor rather than using a screening check (USPSTF 2011) (USPSTF 2013) (USPSTF 2011) (USPSTF 2023).
Pick by the question you have
| Your question | Check to use |
|---|---|
| When should I start screening? | Colon, breast, lung, cervical, prostate |
| What is my risk of getting this cancer? | Breast cancer risk (Gail model), lung cancer risk (PLCOm2012) |
| Does my family history need a closer look? | BRCA family history check |
| Should I take a medicine to lower my risk? | Breast cancer prevention medicines, vitamins for heart and cancer |
| Should I or my child get a vaccine that prevents cancer? | HPV vaccine age check |
| Should I be screened for a less common cancer? | Skin, oral, ovarian, thyroid, pancreatic, testicular, bladder |
Breast cancer
- Breast cancer screening age: the USPSTF advises a mammogram every other year for women from 40 to 74 (USPSTF 2024).
- Breast cancer risk calculator (Gail model): your 5-year and lifetime chance of invasive breast cancer, from questions about your age, periods, children, past breast biopsies and close relatives. It is the model behind the NCI Breast Cancer Risk Assessment Tool (NCI).
- BRCA family history check: the USPSTF recommends a short family history check for women whose personal or family history of breast, ovarian, tubal or peritoneal cancer suggests a harmful BRCA1 or BRCA2 change, and genetic counseling if it is positive (USPSTF 2019).
- Breast cancer prevention medicines: the USPSTF says tamoxifen, raloxifene or aromatase inhibitors should be offered to women 35 and older at increased risk who have a low risk of side effects, and not used routinely by others (USPSTF 2019).
Lung cancer
- Lung cancer screening eligibility: the USPSTF recommends a low-dose CT scan every year for adults aged 50 to 80 with a 20 pack-year smoking history who smoke now or quit within the past 15 years (USPSTF 2021). The check also works out your pack-years.
- Lung cancer risk calculator (PLCOm2012): your chance of a lung cancer diagnosis in the next 6 years, for people aged 55 to 74 who have ever smoked, from a model built on a large US screening trial (Tammemagi 2013).
Colon cancer
- Colon cancer screening age: the USPSTF recommends colorectal cancer screening for adults from 45 to 75, and offering it selectively from 76 to 85 (USPSTF 2021). The check also covers when family history changes the plan.
Cervical cancer
- Cervical cancer screening: the USPSTF recommends a Pap test every 3 years from 21 to 29, and from 30 to 65 a Pap test every 3 years, an HPV test every 5 years or a cotest every 5 years (USPSTF 2018).
- HPV vaccine age check: CDC's vaccine advisory committee (ACIP) routinely recommends the HPV vaccine at 11 or 12, catch-up through age 26, and a shared decision with a clinician for some adults aged 27 through 45 (ACIP 2019).
Prostate cancer
- Prostate cancer screening: the USPSTF says a PSA test from 55 to 69 is a personal choice to make with your doctor, and recommends against PSA screening from 70 (USPSTF 2018).
Skin cancer
- Skin cancer screening: the USPSTF found the evidence insufficient to weigh the benefits and harms of a visual skin exam by a clinician for adults without symptoms (I statement) (USPSTF 2023).
- Skin cancer prevention: the USPSTF recommends counseling on sun protection for fair-skinned people from 6 months to 24 years, and offering it selectively to fair-skinned adults over 24 (USPSTF 2018).
Oral cancer
- Oral cancer screening: the USPSTF found the evidence insufficient to weigh the benefits and harms of a mouth exam by a primary care clinician for adults without symptoms (I statement) (USPSTF 2013).
Other cancers
For these cancers, the USPSTF recommends against screening people without symptoms (D) or found the evidence insufficient (I). Each check explains what that means for you and who the advice does not cover.
- Ovarian cancer screening: recommended against for women without symptoms (D) (USPSTF 2018).
- Thyroid cancer screening: recommended against for adults without symptoms (D) (USPSTF 2017).
- Pancreatic cancer screening: recommended against for adults without symptoms (D) (USPSTF 2019).
- Testicular cancer screening: recommended against for males without symptoms (D) (USPSTF 2011).
- Bladder cancer screening: evidence insufficient for adults without symptoms (I) (USPSTF 2011).
- Vitamins for heart and cancer: recommended against beta carotene and vitamin E (D); evidence insufficient for multivitamins (I) (USPSTF 2022).
What these checks cannot do
A risk score or screening check cannot tell you whether you have cancer. The two risk calculators give an estimate for groups of people like you, not a diagnosis, and only for the cancer and the ages they were built for (NCI) (Tammemagi 2013). Screening advice is for people without symptoms and at average risk unless a check says otherwise. A strong family history, a known gene change or past cancer can mean a different plan, so talk with your doctor.
See all cancer screening checks or the screening tests by age guide.
Sources
- US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
- US Preventive Services Task Force. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331(22):1918-1930. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
- National Cancer Institute. Breast Cancer Risk Assessment Tool: About the Tool, and the tool's eligibility questions and caveats (ages 35 to 85; not for women with a history of breast cancer, DCIS or LCIS, chest radiation for Hodgkin lymphoma, or a BRCA mutation or other hereditary syndrome). bcrisktool.cancer.gov/about.html
- US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(7):652. www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
- US Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(9):857-867. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
- US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962-970. www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
- Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368(8):728-736. Free full text: PMC3929969. doi.org/10.1056/NEJMoa1211776
- US Preventive Services Task Force. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674-686. www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
- Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698-702. doi:10.15585/mmwr.mm6832a3. PMCID PMC6818701. CDC, public domain. Recommendations, Box and footnotes (ages, dose schedules, pregnancy). pmc.ncbi.nlm.nih.gov/articles/PMC6818701/
- US Preventive Services Task Force. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(18):1901-1913. www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
- US Preventive Services Task Force. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(15):1290-1295. www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening
- US Preventive Services Task Force. Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(11):1134. www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-counseling
- Moyer VA; US Preventive Services Task Force. Screening for oral cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(1):55-60. www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening
- US Preventive Services Task Force. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(6):588-594. www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
- US Preventive Services Task Force. Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(18):1882-1887. www.uspreventiveservicestaskforce.org/uspstf/recommendation/thyroid-cancer-screening
- US Preventive Services Task Force. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019;322(5):438-444. www.uspreventiveservicestaskforce.org/uspstf/recommendation/pancreatic-cancer-screening
- US Preventive Services Task Force. Screening for Testicular Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. Ann Intern Med. 2011;154(7):483-486. www.uspreventiveservicestaskforce.org/uspstf/recommendation/testicular-cancer-screening
- Moyer VA; US Preventive Services Task Force. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2011;155(4):246-251. www.uspreventiveservicestaskforce.org/uspstf/recommendation/bladder-cancer-in-adults-screening
- US Preventive Services Task Force. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;327(23):2326-2333. www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
Written and maintained by the uncovermyrisk.com editorial team. We do not have a medical reviewer; every claim links to its primary source above. Last reviewed: 2026-11-04. Spotted an error? See About.